Neuroprotective Effect of S-trans, Trans-farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer’s Disease

References

• Lane CA, Hardy J, Schott JM. Alzheimer’s disease. Eur J Neurol. 2018;25(1):59–70. doi:10.1111/ene.2018.25.issue-128872215
   PubMed Web of Science ®Google Scholar
• Schmidt-Hieber C, Jonas P, Bischofberger J. Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus. Nature. 2004;429(6988):184–187. doi:10.1038/nature0255315107864
   PubMed Web of Science ®Google Scholar
• Winocur G, Wojtowicz JM, Sekeres M, Snyder JS, Wang S. Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus. 2006;16(3):296–304. doi:10.1002/(ISSN)1098-106316411241
   PubMed Web of Science ®Google Scholar
• Anacker C, Hen R. Adult hippocampal neurogenesis and cognitive flexibility – linking memory and mood. Nat Rev Neurosci. 2017;18(6):335–346. doi:10.1038/nrn.2017.4528469276
   PubMed Web of Science ®Google Scholar
• Hamilton LK, Aumont A, Julien C, Vadnais A, Calon F, Fernandes KJ. Widespread deficits in adult neurogenesis precede plaque and tangle formation in the 3xTg mouse model of Alzheimer’s disease. Eur J Neurosci. 2010;32(6):905–920. doi:10.1111/j.1460-9568.2010.07379.x20726889
   PubMed Web of Science ®Google Scholar
• Lazarov O, Hollands C. Hippocampal neurogenesis: learning to remember. Prog Neurobiol. 2016;138–140:1–18. doi:10.1016/j.pneurobio.2015.12.006
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. J Clin Invest. 2002;110(10):1375–1381. doi:10.1172/JCI021678312438432
   PubMed Web of Science ®Google Scholar
• Kirouac L, Rajic AJ, Cribbs DH, Padmanabhan J. Activation of Ras-ERK signaling and GSK-3 by amyloid precursor protein and amyloid beta facilitates neurodegeneration in Alzheimer’s disease. eNeuro. 2017;4:2. doi:10.1523/ENEURO.0149-16.2017
   Web of Science ®Google Scholar
• Murphy LO, Blenis J. MAPK signal specificity: the right place at the right time. Trends Biochem Sci. 2006;31(5):268–275. doi:10.1016/j.tibs.2006.03.00916603362
   PubMed Web of Science ®Google Scholar
• Lee MS, Kao SC, Lemere CA, et al. APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol. 2003;163(1):83–95.14557249
   PubMed Web of Science ®Google Scholar
• Coleman ML, Marshall CJ, Olson MF. Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J. 2003;22(9):2036–2046. doi:10.1093/emboj/cdg18912727871
   PubMed Web of Science ®Google Scholar
• Arendt T, Holzer M, Stöbe A, et al. Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer’s disease that eventually results in cell death. Ann N Y Acad Sci. 2000;920:249–255. doi:10.1111/j.1749-6632.2000.tb06931.x11193159
   PubMed Web of Science ®Google Scholar
• Koseoglu MM, Ozdilek BA, Djakbarova U, Gulusur A. Targeting Ras activity prevented amyloid beta-induced aberrant neuronal cell cycle re-entry and death. Curr Alzheimer Res. 2016;13(11):1267–1276. doi:10.2174/156720501366616062507452027357648
   PubMed Web of Science ®Google Scholar
• Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. Understanding Ras: ‘it ain’t over ‘til it’s over’. Trends Cell Biol. 2000;10(4):147–154. doi:10.1016/S0962-8924(00)01740-210740269
   PubMed Web of Science ®Google Scholar
• Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer’s disease. J Neurosci. 2001;21(12):4125–4133. doi:10.1523/JNEUROSCI.21-12-04125.200111404397
   PubMed Web of Science ®Google Scholar
• Niv H, Gutman O, Kloog Y, Henis YI. Activated K-Ras and H-Ras display different interactions with saturable nonraft sites at the surface of live cells. J Cell Biol. 2002;157(5):865–872. doi:10.1083/jcb.20020200912021258
   PubMed Web of Science ®Google Scholar
• Kloog Y, Cox AD, Sinensky M. Concepts in Ras-directed therapy. Expert Opin Investig Drugs. 1999;8(12):2121–2140. doi:10.1517/13543784.8.12.2121
   PubMedGoogle Scholar
• Wang Y, Chen T, Yuan Z, et al. Ras inhibitor S-trans, trans-farnesylthiosalicylic acid enhances spatial memory and hippocampal long-term potentiation via up-regulation of NMDA receptor. Neuropharmacology. 2018;139:257–267. doi:10.1016/j.neuropharm.2018.03.02629578035
   PubMed Web of Science ®Google Scholar
• Jin H, Chen T, Li G, et al. Dose-dependent neuroprotection and neurotoxicity of simvastatin through reduction of Farnesyl Pyrophosphate in mice treated with intracerebroventricular injection of Aβ 1-42. J Alzheimers Dis. 2016;50(2):501–516. doi:10.3233/JAD-15078226757191
   PubMed Web of Science ®Google Scholar
• Shohami E, Yatsiv I, Alexandrovich A, et al. The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid exerts long-lasting neuroprotection in a mouse closed head injury model. J Cereb Blood Flow Metab. 2003;23(6):728–738. doi:10.1097/01.WCB.0000067704.86573.8312796721
   PubMed Web of Science ®Google Scholar
• Robert D, Mays W, Mays RW, et al. Development of an allogeneic adherent stem cell therapy for treatment of ischemic stroke. J Exp Stroke Transl Med. 2010;3:34–46. doi:10.6030/1939-067X-3.1.34
   Google Scholar
• Wang C, Chen T, Li G, Zhou L, Sha S, Chen L. Simvastatin prevents β-amyloid(25–35)-impaired neurogenesis in hippocampal dentate gyrus through α7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate. Neuropharmacology. 2015;97:122–132. doi:10.1016/j.neuropharm.2015.05.02026051402
   PubMed Web of Science ®Google Scholar
• Li L, Xu B, Zhu Y, Chen L, Sokabe M, Chen L. DHEA prevents Aβ25-35-impaired survival of newborn neurons in the dentate gyrus through a modulation of PI3K-Akt-mTOR signaling. Neuropharmacology. 2010;59(4–5):323–333. doi:10.1016/j.neuropharm.2010.02.00920167228
   PubMed Web of Science ®Google Scholar
• Rao MS, Shetty AK. Efficacy of doublecortin as a marker to analyse the absolute number and dendritic growth of newly generated neurons in the adult dentate gyrus. Eur J Neurosci. 2004;19(2):234–246. doi:10.1111/j.0953-816X.2003.03123.x14725617
   PubMed Web of Science ®Google Scholar
• Yun HM, Kim HS, Park KR, et al. Placenta-derived mesenchymal stem cells improve memory dysfunction in an Aβ1-42-infused mouse model of Alzheimer’s disease. Cell Death Dis. 2013;4:e958. doi:10.1038/cddis.2013.49024336078
   PubMed Web of Science ®Google Scholar
• Verret L, Jankowsky JL, Xu GM, Borchelt DR, Rampon C. Alzheimer’s-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J Neurosci. 2007;27(25):6771–6780. doi:10.1523/JNEUROSCI.5564-06.200717581964
   PubMed Web of Science ®Google Scholar
• Kempermann G, Gast D, Kronenberg G, Yamaguchi M, Gage FH. Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice. Development. 2003;130(2):391–399. doi:10.1242/dev.0020312466205
   PubMed Web of Science ®Google Scholar
• Brown JP, Couillard-Després S, Cooper-Kuhn CM, Winkler J, Aigner L, Kuhn HG. Transient expression of doublecortin during adult neurogenesis. J Comp Neurol. 2003;467(1):1–10. doi:10.1002/cne.v467:114574675
   PubMed Web of Science ®Google Scholar
• Choi SH, Bylykbashi E, Chatila ZK, et al. Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer’s mouse model. Science. 2018;361:6406. doi:10.1126/science.aan8821
   Web of Science ®Google Scholar
• Bordet R, Ihl R, Korczyn AD, et al. Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus report. BMC Med. 2017;15(1):107. doi:10.1186/s12916-017-0869-628539119
   PubMed Web of Science ®Google Scholar
• Zhao C, Teng EM, Summers RG Jr, Ming GL, Gage FH. Distinct morphological stages of dentate granule neuron maturation in the adult mouse hippocampus. J Neurosci. 2006;26(1):3–11. doi:10.1523/JNEUROSCI.3648-05.200616399667
   PubMed Web of Science ®Google Scholar
• Haughey NJ, Liu D, Nath A, Borchard AC, Mattson MP. Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer’s disease. Neuromolecular Med. 2002;1(2):125–135. doi:10.1385/NMM:1:2:12512025858
   PubMed Web of Science ®Google Scholar
• Radak Z, Hart N, Sarga L, et al. Exercise plays a preventive role against Alzheimer’s disease. J Alzheimers Dis. 2010;20(3):777–783. doi:10.3233/JAD-2010-09153120182027
   PubMed Web of Science ®Google Scholar
• Lamb SE, Sheehan B, Atherton N; DAPA Trial Investigators, et al.. Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial. BMJ. 361:k1675.
   PubMedGoogle Scholar
• Gärtner U, Holzer M, Arendt T. Elevated expression of p21ras is an early event in Alzheimer’s disease and precedes neurofibrillary degeneration. Neuroscience. 1999;91(1):1–5. doi:10.1016/S0306-4522(99)00059-710336054
   PubMed Web of Science ®Google Scholar
• Shaul YD, Seger R. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta. 2007;1773(8):1213–1226. doi:10.1016/j.bbamcr.2006.10.00517112607
   PubMed Web of Science ®Google Scholar
• Lee HG, Casadesus G, Zhu X, et al. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer’s disease. Neurochem Int. 2009;54(2):84–88. doi:10.1016/j.neuint.2008.10.01319114068
   PubMed Web of Science ®Google Scholar
• Ye X, Carew TJ. Small G protein signaling in neuronal plasticity and memory formation: the specific role of ras family proteins. Neuron. 2010;68(3):340–361. doi:10.1016/j.neuron.2010.09.01321040840
   PubMed Web of Science ®Google Scholar
• Li W, Cui Y, Kushner SA, et al. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol. 2005;15(21):1961–1967. doi:10.1016/j.cub.2005.09.04316271875
   PubMed Web of Science ®Google Scholar
• Pennisi G, Ferri R, Lanza G, et al. Transcranial magnetic stimulation in Alzheimer’s disease: a neurophysiological marker of cortical hyperexcitability. J Neural Transm (Vienna). 2011;118(4):587–598. doi:10.1007/s00702-010-0554-921207079
   PubMed Web of Science ®Google Scholar
• Cantone M, Bramanti A, Lanza G, et al. Cortical plasticity in depression. ASN Neuro. 2017;9(3):1759091417711512. doi:10.1177/175909141771151228629225
   PubMed Web of Science ®Google Scholar
• McTaggart SJ. Isoprenylated proteins. Cell Mol Life Sci. 2006;63(3):255–267. doi:10.1007/s00018-005-5298-616378247
   PubMed Web of Science ®Google Scholar
• Chambard JC, Lefloch R, Pouysségur J, Lenormand P. ERK implication in cell cycle regulation. Biochim Biophys Acta. 2007;1773(8):1299–1310. doi:10.1016/j.bbamcr.2006.11.01017188374
   PubMed Web of Science ®Google Scholar
• Tamemoto H, Kadowaki T, Tobe K, et al. Biphasic activation of two mitogen-activated protein kinases during the cell cycle in mammalian cells. J Biol Chem. 1992;267(28):20293–20297.1400347
   PubMed Web of Science ®Google Scholar
• Yan Y, Spieker RS, Kim M, Stoeger SM, Cowan KH. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation. Oncogene. 2005;24(20):3285–3296. doi:10.1038/sj.onc.120849215735702
   PubMed Web of Science ®Google Scholar